AzTrials
AzTrials

Patient SafetyQUALI-IINCT04800796

Transfer of Standard Operating Procedures in Anesthesiology

An observational study of Patient Safety, run by Johannes Gutenberg University Mainz at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients safety and high Quality Performance built up the centre of anesthesiology. Standard operating procedures based on the Helsinki declaration may help to increase the Patient safety and decreased adverse Events or complications. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Patient Safety
What is being tested?
Audiovisual
How many people
60 participants
Where
1 siteGermany
Study dates
1 Mar 2021to 7 Mar 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: anesthesia physicians who participating in a Scenario training

Who may be able to join

  • anesthesia residents
  • anesthesia consultants

Who cannot join

  • nurses
  • students

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University

    Mainz, Rhineland-Palatinate, D55131

Other trials in Germany

About this study

Official title: Evaluation From Didactic and Structural Transfer of Standard Operating Procedures in Anesthesiology

Patients safety and high Quality Performance built up the centre of anesthesiology. Standard operating procedures based on the Helsinki declaration may help to increase the Patient safety and decreased adverse Events or complications.

Read the detailed description

The Primary endpoint is the comparison of a Intervention Group with audiovisually blended learning concept and a Standard Group receiving the Standard operating procedures via E-Mail and Confirmation when reading.

Conditions
Patient Safety
Being tested
Audiovisual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AudiovisualOther

    Receive blended learning before and reading the Standard operating procedure

Study groups in NCT04800796
Study groupRoleWhat they receive
Intervention GroupIntervention Group with audiovisually blended learning concept
Receives: Other: Audiovisual
Standard groupStandard Group receiving the Standard operating procedures via E-Mail and Confirmation when reading.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of SOP deviations

    SOP deviations during scenario training

    Measured: 12 minutes after start scenario

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2021
  2. Study start1 Mar 2021
  3. Primary completion1 Mar 2021
  4. Study completion7 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04800796
Sponsor's protocol ID
JohannesGUQ
Acronym
QUALI-II
Status last verified
Mar 2021
First submitted
9 Mar 2021
Last updated
16 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Patient Safety, run by Johannes Gutenberg University Mainz at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of SOP deviations (time frame: 12 minutes after start scenario). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in